Ovobiomanufacturing
1 known investors
OVO Biomanufacturing offers a cloud-based software platform that helps viral vaccine manufacturers manage and reduce defective interfering particles (DIPs) to improve production yields. Using Next Generation Sequencing data, the platform guides producers to optimise DIP populations when creating working seed stocks for live attenuated and inactivated viral vaccines, with an initial focus on the influenza vaccine market.
Founders & leadership
CO
Co-founder of OVOCo-founder